Greenwich LifeSciences, Inc. (GLSI) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.82M | +82.9% |
| 2024 | $3.19M | +981.9% |
| 2023 | $294.4K | +12.0% |
| 2022 | $262.9K | -31.7% |
| 2021 | $385.2K | -63.2% |
| 2020 | $1.05M | -24.1% |
| 2019 | $1.38M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.82M | +82.9% |
| 2024 | $3.19M | +981.9% |
| 2023 | $294.4K | +12.0% |
| 2022 | $262.9K | -31.7% |
| 2021 | $385.2K | -63.2% |
| 2020 | $1.05M | -24.1% |
| 2019 | $1.38M | — |